Cannell & Spears’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,851
Closed -$1.42M 410
2025
Q1
$1.42M Sell
15,851
-330
-2% -$29.5K 0.03% 208
2024
Q4
$1.29M Sell
16,181
-2,311
-12% -$200K 0.03% 220
2024
Q3
$1.66M Buy
18,492
+1,695
+10% +$143K 0.03% 196
2024
Q2
$1.32M Sell
16,797
-8,391
-33% -$688K 0.03% 203
2024
Q1
$2.2M Buy
+25,188
New +$2.15M 0.05% 171
2022
Q3
Sell
-3,104
Closed -$279K 204
2022
Q2
$279K Sell
3,104
-106
-3% -$10.7K 0.03% 176
2022
Q1
$356K Hold
3,210
0.03% 167
2021
Q4
$332K Sell
3,210
-3,798
-54% -$440K 0.02% 174
2021
Q3
$878K Buy
7,008
+433
+7% +$56K 0.06% 104
2021
Q2
$816K Buy
6,575
+4,688
+248% +$589K 0.06% 111
2021
Q1
$223K Sell
1,887
-123
-6% -$14.4K 0.02% 212
2020
Q4
$235K Sell
2,010
-3,920
-66% -$432K 0.02% 205
2020
Q3
$616K Buy
5,930
+3,020
+104% +$303K 0.06% 111
2020
Q2
$267K Hold
2,910
0.03% 172
2020
Q1
$262K Buy
+2,910
New +$310K 0.03% 165
2014
Q1
Sell
-10,756
Closed -$617K 121
2013
Q4
$617K Hold
10,756
0.08% 64
2013
Q3
$573K Buy
+10,756
New +$579K 0.07% 66

Other funds holding MDT

Cannell & Spears's MDT Position: Q2 2025 in Review

Cannell & Spears sold out of Medtronic (MDT) in Q2 2025, closing a stake of 15,851 shares — an estimated $1.42M sold.

Cannell & Spears first reported a position in MDT in Q3 2013 and held it in 17 quarters. The position peaked at $2.2M in Q1 2024. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Cannell & Spears reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Cannell & Spears sold 15,851 Medtronic shares in Q2 2025, an estimated $1.42M.
  • Cannell & Spears first reported a position in Medtronic in Q3 2013 and held it in 17 quarters.
  • Cannell & Spears's Medtronic position peaked at $2.2M in Q1 2024.
  • 2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Cannell & Spears's 13F filing for Q2 2025, filed 14 Aug 2025.